Alzamend Neuro Inc (ALZN)

Finanzdaten der Alzamend Neuro Inc-Aktie (ALZN)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-07-31	2026-04-30	2026-01-31	2025-10-31	2025-07-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	5.38%3.03	2.87	2.20	1.00	2.70
Research and Development	150.23%1.09	0.43	1.28	0.18	1.74
Interest Income/Expense	1,237%0.00	0.00	0.00	0.00	0.00
Operating Income/Loss	5.38%-3.03	-2.87	-2.20	-1.00	-2.70
Nonoperating Income/Loss	273.06%-0.00	0.00	-0.00	-0.00	-0.00
	120.59%-3.03	14.70	-2.20	-1.00	2.70
Attributable To Parent	5.47%-3.03	-2.87	-2.20	-1.00	-2.70
Available To Common Stockholders, Basic	204.53%3.00	-2.87	-2.20	-1.00	-2.70
Basic Average Shares	4.48	-	3.80	3.38	2.11
Diluted Average Shares	4.48	-	3.80	3.38	2.11
Basic Earnings Per Share	-0.68	-	-0.58	-0.30	-1.28
Diluted Earnings Per Share	-0.68	-	-0.58	-0.30	-1.28